sodium polystyrene sulfonate 15000 MG Powder for Oral Suspension
RxNorm concept 2101899, clinical drug (scd). Prescribable name: sodium polystyrene sulfonate 15 GM Powder for Suspension.
- RxCUI
- 2101899
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2101899 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
sodium polystyrene sulfonate 15 to 60 GM Powder for Oral Suspension; sodium polystyrene sulfonate 30 to 50 GM Powder for Rectal Suspension; sodium polystyrene sulfonate 4.1 MEQ in 1 GM Powder for Oral Suspension
Related concepts
- sodium polystyrene sulfonate 15000 MG (SCDC, consists of)
- Powder for Oral Suspension (DF, has dose form)
Linked data
NDCs
- 10135014614
- 10135014617
- 10702003615
- 10702003645
- 11534016615
- 11534016616
- 11534016644
- 13811065653
- 17856002401
- 17856002402
- 17856083101
- 24658076016
- 42806001394
- 42806001396
- 46287001216
- 50488500101
- 51293083197
- 62135034011
- 62135034053
- 62135034062
- 62250066023
- 63629203101
- 63629239001
- 63629884901
- 63629885001
- 70166071210
- 71335285501
- 72162123002
- 72162123007
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2101899 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2101899 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2101899. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.